These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1585928)

  • 1. Diltiazem enhances potassium disposal in subjects with end-stage renal disease.
    Solomon R; Dubey A
    Am J Kidney Dis; 1992 May; 19(5):420-6. PubMed ID: 1585928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of the diurnal variation of aldosterone and cortisol in anephric subjects.
    Cooke CR; Whelton PK; Moore MA; Caputo RA; Bledsoe T; Walker WG
    Kidney Int; 1979 Jun; 15(6):669-75. PubMed ID: 572442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diurnal rhythm of cortisol and aldosterone plasma levels in patients with chronic renal insufficiency].
    Ivić MA; Micić M; Stefanović V
    Srp Arh Celok Lek; 1996; 124(5-6):115-9. PubMed ID: 9102829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic-mediated extrarenal potassium disposal in patients with end-stage renal disease: effect of propranolol.
    Yang WC; Huang TP; Ho LT; Chung HM; Chan YL; Batlle DC
    Miner Electrolyte Metab; 1986; 12(3):186-93. PubMed ID: 2873504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone response to insulin-induced hypoglycemia in hemodialysis patients.
    Ramirez G; Ganguly A; Bruegemeyer C; Gomez-Sanchez C
    Am J Nephrol; 1989; 9(3):215-21. PubMed ID: 2547316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary potassium and laxatives as regulators of colonic potassium secretion in end-stage renal disease.
    Mathialahan T; Sandle GI
    Nephrol Dial Transplant; 2003 Feb; 18(2):341-7. PubMed ID: 12543890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The regulation of plasma aldosterone in hemodialysis patients].
    Louis F; Zwahlen A; Favre H; Vallotton M
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1882-4. PubMed ID: 7006078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the control of plasma aldosterone concentration in normal man. I. Response to posture, acute and chronic volume depletion, and sodium loading.
    Williams GH; Cain JP; Dluhy RG; Underwood RH
    J Clin Invest; 1972 Jul; 51(7):1731-42. PubMed ID: 4338121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of insulin-renin-aldosterone-potassium interrelationship in normal subjects, disrupted in chronic hemodialysis patients.
    Farfel Z; Iaina A; Eliahou HE
    J Clin Endocrinol Metab; 1978 Jul; 47(1):9-17. PubMed ID: 400716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral glucose administration on serum potassium concentration in hemodialysis patients.
    Muto S; Sebata K; Watanabe H; Shoji F; Yamamoto Y; Ohashi M; Yamada T; Matsumoto H; Mukouyama T; Yonekura T; Namiki S; Kusano E
    Am J Kidney Dis; 2005 Oct; 46(4):697-705. PubMed ID: 16183425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of plasma aldosterone during hemodialysis in patients with terminal renal failure.
    Vetter W; Záruba K; Armbruster H; Beckerhoff R; Nussberger J; Furrer J; Fontana A; Siegenthaler W
    Nephron; 1977; 18(2):114-23. PubMed ID: 857174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease.
    Allon M; Dansby L; Shanklin N
    Am J Med; 1993 May; 94(5):475-482. PubMed ID: 8498392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of serum potassium during fasting in patients with end-stage renal disease.
    Gifford JD; Rutsky EA; Kirk KA; McDaniel HG
    Kidney Int; 1989 Jan; 35(1):90-4. PubMed ID: 2651754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients.
    Gross E; Rothstein M; Dombek S; Juknis HI
    Am J Kidney Dis; 2005 Jul; 46(1):94-101. PubMed ID: 15983962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients.
    Kim HJ
    Nephron; 1996; 72(3):476-82. PubMed ID: 8852501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal variation of plasma concentrations of cortisol, aldosterone and electrolytes in the ram.
    Mesbah S; Brudieux R
    Horm Metab Res; 1982 Jun; 14(6):320-3. PubMed ID: 6889565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of calcium-channel blockers on calcium-phosphate metabolism in patients with end-stage renal disease.
    Lippuner K; Zehnder HJ; Casez JP; Takkinen R; Descoeudres C; Jaeger P
    Nephrol Dial Transplant; 1996 Jan; 11(1):70-4. PubMed ID: 8649655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma aldosterone in patients with end stage kidney disease.
    Weidmann P; Lupu AN; Schroth P; Maxwell MH
    Proc Eur Dial Transplant Assoc; 1972; 9():147-53. PubMed ID: 4668907
    [No Abstract]   [Full Text] [Related]  

  • 19. Impairment of beta 2-adrenoceptor-stimulated potassium uptake in end-stage renal disease.
    Stemmer CL; Perez GO; Oster JR
    J Clin Pharmacol; 1987 Aug; 27(8):628-31. PubMed ID: 2821083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of hemodialysis on plasma aldosterone in anephric patients (author's transl)].
    Vetter W; Záruba K; Armbruster H; Beckerhoff R; Siegenthaler W
    Klin Wochenschr; 1975 Jan; 53(1):17-20. PubMed ID: 1123892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.